Full Press Release Details
BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in five upcoming investor conferences:
Praxis management will be presenting a corporate overview at the 45th Annual TD Cowen Health Care Conference, taking place at the Boston Marriott Copley Place in Boston on Wednesday, March 5, 2025 at 9:10a.m. EDT. A live webcast of the event will be available through this link.
Praxis management will also be participating in a fireside chat at the Leerink Partners Global Healthcare Conference, taking place at the W South Beach Hotel in Miami on Monday, March 10, 2025 at 3:40p.m. EDT. A live webcast of the event will be available through this link.
Praxis management will also be participating in one-on-one investor meetings at the Jefferies Biotech on the Bay Summit, taking place at the Ritz Carlton South Beach Hotel in Miami on Tuesday, March 11, 2025.
Praxis management will also be participating in a fireside chat at the Barclays 27th Annual Global Healthcare Conference, taking place at the Loews Miami South Beach Hotel in Miami on Wednesday, March 12, 2025 at 2:30p.m. EDT. A live webcast of the event will be available through this link.
Praxis management will also be participating in a fireside chat at the UBS Virtual CNS Day, taking place on March 17, 2025 at 9:30a.m. EDT. A live webcast of the event will be available through this link.
The Company will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.
Replays of the webcasted events will also be available through the “Events & Presentations” page under the “Investors + Media” section of the company’s website for 90 days.
Contact Data
Contact
With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.